World / Genetics
Data From Mipomersen Phase 3 Trial In heFH Patients Presented At ESC
01.09.2010 10:13
medicalnewstoday.com
Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden...
World
Genetics
Physically Active Lifestyle May Reduce Genetic Predisposition To Obesity
01.09.2010 06:16
medicalnewstoday.com
New research from the UK suggests that living an active lifestyle can reduce people's genetic predisposition to obesity by about 40 per cent, challenging a popular view that exercise doesn't help people lose weight if they are genetically predisposed to obesity...
World
Genetics
« Previous
0
Next »
English